Bemarituzumab (Anti-FGFR2 / CD332)
Product Specifications
CAS Number
1952272-74-0
Target
FGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor) . Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740304-100 1x 100 µL
CD106 / VCAM1 (B-K9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470226-100 1x 100 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471133-100 1x 100 µL
CD74 (CLIP/1133), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740992-100 1x 100 µL
SOX10 (SOX10/992), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details